These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 470503)

  • 21. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting.
    Nunn AV; Gardner LC; Cox TM
    Q J Med; 1987 Jul; 64(243):589-99. PubMed ID: 3671663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Normal activity of uroporphyrinogen I synthase during an attack of acute intermittent porphyria].
    Kostrzewska E; Gregor A
    Pol Tyg Lek; 1980 Nov; 35(46):1785-6. PubMed ID: 7243643
    [No Abstract]   [Full Text] [Related]  

  • 23. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation.
    Doss M; von Tiepermann R; Schneider J; Schmid H
    Klin Wochenschr; 1979 Oct; 57(20):1123-7. PubMed ID: 513604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified spectrophotometric assay for porphobilinogen deaminase: its application in the detection of both carriers and patients with acute intermittent porphyria.
    Vázquez-Prado J; Sánchez-Anzaldo FJ; Ruiz-Argüelles GJ; Marín-López E; Lobato-Mendizábal E
    J Inherit Metab Dis; 1995; 18(1):66-71. PubMed ID: 7623445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of clinical manifestations in acute intermittent porphyria].
    Kaszewska-Jablońska I; Bielawski W; Bardzik I
    Pol Arch Med Wewn; 1973 Jun; 50(6):545-53. PubMed ID: 4732435
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acute intermittent porphyria: uroporphyrinogen-I-synthetase activity in erythrocytes as a diagnostic index].
    Formgren B; Wetterberg L
    Lakartidningen; 1978 May; 75(19):1921-4. PubMed ID: 651454
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
    Forman DT
    Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the biochemical pathogenesis of acute intermittent porphyria].
    Heilmeyer L
    Munch Med Wochenschr; 1969 Apr; 111(16):905-9. PubMed ID: 5819143
    [No Abstract]   [Full Text] [Related]  

  • 30. Mutations in acute intermittent porphyria detected by ELISA measurement of porphobilinogen deaminase.
    Lannfelt L; Wetterberg L; Gellerfors P; Lilius L; Floderus Y; Thunell S
    J Clin Chem Clin Biochem; 1989 Nov; 27(11):857-62. PubMed ID: 2607315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal diagnosis of acute intermittent porphyria.
    Sassa S; Kappas A
    N Engl J Med; 1976 Dec; 295(24):1381. PubMed ID: 980088
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of delta-aminolaevulinic acid and porphobilinogen in human erythrocytes in acute intermittent porphyria.
    Doss M
    Enzyme; 1973; 16(1):343-53. PubMed ID: 4791053
    [No Abstract]   [Full Text] [Related]  

  • 33. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria].
    Gregor A; Kocyłowski M; Kostrzewska E
    Przegl Lek; 1986; 43(11):703-5. PubMed ID: 3575772
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diagnostic criteria and neuropsychiatric leading symptoms in acute intermittent porphyria--results of a field study].
    Druschky KF; Schaller KH
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():668-71. PubMed ID: 1029256
    [No Abstract]   [Full Text] [Related]  

  • 36. Laboratory evaluation in porphyria.
    Bissell DM
    Semin Liver Dis; 1982 May; 2(2):100-7. PubMed ID: 6753160
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hematin treatment of acute intermittent porphyria. A case report (author's transl)].
    Marchiori PE; de Assis JL; Scaff M; Do Serro-Azul LG; Moraes EC; Bacheschi LA; Yassuda N
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):325-33. PubMed ID: 531276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 39. Porphobilinogen-synthase (delta-aminolevulinic acid dehydratase) deficiency in bone marrow cells of two patients with porphobilinogen-synthase defect acute porphyria.
    Doss M; Tiepermann RV; Schneider J
    Klin Wochenschr; 1983 Jul; 61(14):699-702. PubMed ID: 6887758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Letter: Determination of uroporphyrinogen I synthetase in intermittent acute porphyria. 7 cases].
    Koehl C; Abecassis J; Wertenschlag J
    Nouv Presse Med; 1975 Nov; 4(38):2735. PubMed ID: 1202467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.